NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Patent Uncertainty and Drug Launch Timing Poise a Pivotal Question for Corcept Therapeutics (CORT)

Wolfe Research recently initiated coverage on Corcept Therapeutics with a Peerperform rating, highlighting both the company’s ongoing patent litigation and antitrust concerns, as well as the potential upside from its drug candidate relacorilant ahead of its upcoming PDUFA date for hypercortisolism on December 30, 2025. Although Corcept outperformed expectations for earnings per share in the third quarter of 2025, it reported revenue below analyst forecasts, contributing to investor caution...
NYSEAM:NHC
NYSEAM:NHCHealthcare

How National HealthCare’s Senior Care Expansion Impacts Valuation After 18.5% Year-to-Date Rally

Wondering if National HealthCare is a bargain or priced for perfection? Let’s dig into what’s driving the value of this long-established healthcare name. The stock has climbed an impressive 18.5% year-to-date, despite some recent volatility. This suggests that investors are both optimistic and newly attentive to potential risks. National HealthCare has hit headlines lately after expanding its network of senior care facilities and pushing forward with strategic partnerships. These moves have...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Could SaaS Tools Define the Next Phase of Garrett Motion's (GTX) Technology Advantage?

On November 19, 2025, PTC announced an expansion of its partnership with Garrett Motion, with Garrett adopting PTC's Codebeamer+ application lifecycle management and Windchill+ product lifecycle management solutions to further its SaaS-driven transformation. This expanded collaboration builds on Garrett’s enterprise-wide use of cloud-native tools, aiming to unify engineering disciplines, improve product data accessibility, and accelerate the integration of advanced technologies such as...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV): Evaluating Valuation After Strong Share Price Gains in Defense Tech

AeroVironment (AVAV) shares have caught the interest of investors following shifting trends in the defense technology sector. With the stock posting a nearly 80% gain year to date, many are taking a closer look at what is fueling its momentum. See our latest analysis for AeroVironment. This year’s strong run has put AeroVironment firmly in the spotlight as the defense sector adapts to new demands, with shares up nearly 80% since January and the latest price retreating only slightly from...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS): Exploring Valuation After Recent Share Price Slide

After a mixed few months for Dutch Bros (BROS) shares, investors are watching the stock for signs of stabilization. Over the past three months, the coffee chain’s share price has slid roughly 20% as market sentiment has shifted. See our latest analysis for Dutch Bros. While Dutch Bros’ share price has struggled lately, falling over 20% in the past three months, this move follows a stretch of mixed momentum and shifting risk sentiment across consumer stocks. The recent 1-year total shareholder...
NYSE:K
NYSE:KFood

Kellanova (K): Exploring Valuation After Steady Share Performance and Recent Growth Trends

Kellanova (NYSE:K) shares have stayed relatively steady this week, closing at $83.42 with modest gains of 5% over the past month. Investors continue to assess recent stock performance along with steady revenue and net income growth. See our latest analysis for Kellanova. After holding fairly stable through recent weeks, Kellanova’s stock is showing subtle momentum with a 4.3% three-month share price return and a 6.2% total shareholder return over the past year. This steady climb suggests...